Also, our study identified a lower placental IHC expression of the PlGF in pregnancies with CHD fetuses compared to controls, but no difference in the placental immunostaining pattern for the VEGFR-1 between the two groups. The gene discussed is FLT1; the disease is coronary artery disorder.